北美分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域(肿瘤、传染病、基因检测、心脏病、免疫系统疾病等)、技术(聚合酶链式反应、等温核酸扩增技术、DNA 测序和下一代测序、DNA 微阵列、原位杂交等)、产品和服务(检测和试剂盒、仪器以及服务和软件)以及最终用户(医院和诊所、诊断实验室、研究和学术机构以及其他的)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 125    |    Report Code: TIPRE00026717    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Molecular Diagnostics Market

北美分子诊断市场预计将从2022年的80.5648亿美元增长到2030年的207.4038亿美元。预计2022年至2030年复合年增长率为12.5%。    

新产品的开发和即时检测需求的增加推动了北美分子诊断市场

<即时检测是医学的一个分支,其分析范围和临床应用不断发展。即时检测解决方案提供商提供用于各种评估的产品,从血糖测量到粘弹性凝血测定。这些测试消除了运输和制备临床样本的时间,使专业人员能够在更短的时间内做出有关额外测试或治疗的临床决策。这种新兴的医疗保健解决方案正在被患者和医疗保健服务提供商积极采用。即时检测广泛用于治疗、诊断和患者监测等应用。此外,即时护理产品和服务可帮助医疗保健提供者满足患者的需求。居家医疗的需求。事实证明,这些产品和服务在 COVID-19 大流行期间特别有用,它们允许患者在家中接受检测,而不用前往诊断或治疗机构,从而降低感染风险。因此,对即时检测的需求不断增长有利于分子诊断市场。

北美分子诊断市场概述

北美分子诊断市场已细分为美国、加拿大和墨西哥。越来越多地采用技术先进的产品,研究和开发的增加。开发活动、大型医疗保健企业的存在以及分子诊断的使用不断增加是推动该地区分子诊断市场增长的关键因素。 2022年,美国在北美分子诊断市场中占据最大份额。

北美分子诊断市场收入及至2030年的预测(百万美元)

< p>

北美分子诊断市场细分

 

北美分子诊断市场细分为疾病领域、技术、产品和服务、最终用户和国家。

根据技术,北美分子诊断市场分为聚合酶链反应(PCR)、原位杂交、等温核酸扩增技术 (INAAT)、DNA 测序和下一代测序 (NGS)、DNA 微阵列等。聚合酶链式反应 (PCR) 领域在 2022 年占据北美分子诊断市场份额最大。聚合酶链式反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。

根据产品和服务,北美分子诊断市场分为检测和试剂盒、仪器、服务和软件。 2022 年,检测和试剂盒领域占据北美分子诊断市场最大份额。

根据最终用户,北美分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构、和别的。到2022年,诊断实验室领域占据北美最大的分子诊断市场份额。

按国家划分,北美分子诊断市场分为美国、加拿大和墨西哥。 2022 年,美国将主导北美分子诊断市场。

雅培实验室、安捷伦科技公司、赛默飞世尔科技公司、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、 Danaher、Siemens Healthineers AG、Novartis AG 和 TBG Diagnostics Limited 是北美分子诊断市场上的一些领先公司。    



North America Molecular Diagnostics Strategic Insights

Strategic insights for North America Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-molecular-diagnostics-market-strategic-framework.webp
Get more information on this report

North America Molecular Diagnostics Report Scope

Report Attribute Details
Market size in 2022 US$ 8,056.48 Million
Market Size by 2030 US$ 20,740.38 Million
Global CAGR (2022 - 2030) 12.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 疾病领域
  • 肿瘤
  • 传染病
  • 基因检测
  • 心脏疾病
  • 免疫系统疾病
By 技术
  • 聚合酶链式反应
  • 等温核酸扩增技术
  • DNA测序和下一代测序
  • DNA微阵列
  • 原位杂交
By 产品和服务
  • 检测试剂盒
  • 仪器
  • 服务和软件
By 最终用户
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Abbott Laboratories
  • Agilent Technologies Inc
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Novartis AG
  • Qiagen NV
  • Siemens Healthineers AG
  • TBG Diagnostics Limited
  • Get more information on this report

    North America Molecular Diagnostics Regional Insights

    The regional scope of North America Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-molecular-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - North America Molecular Diagnostics Market

    1. Abbott Laboratories
    2. Agilent Technologies Inc
    3. bioMerieux SA
    4. Danaher
    5. F. Hoffmann-La Roche Ltd
    6. Illumina Inc
    7. Novartis AG
    8. Qiagen NV
    9. Siemens Healthineers AG
    10. TBG Diagnostics Limited
    11. Thermo Fisher Scientific Inc
    Frequently Asked Questions
    How big is the North America Molecular Diagnostics Market?

    The North America Molecular Diagnostics Market is valued at US$ 8,056.48 Million in 2022, it is projected to reach US$ 20,740.38 Million by 2030.

    What is the CAGR for North America Molecular Diagnostics Market by (2022 - 2030)?

    As per our report North America Molecular Diagnostics Market, the market size is valued at US$ 8,056.48 Million in 2022, projecting it to reach US$ 20,740.38 Million by 2030. This translates to a CAGR of approximately 12.5% during the forecast period.

    What segments are covered in this report?

    The North America Molecular Diagnostics Market report typically cover these key segments-

  • 疾病领域 (肿瘤, 传染病, 基因检测, 心脏疾病, 免疫系统疾病)
  • 技术 (聚合酶链式反应, 等温核酸扩增技术, DNA测序和下一代测序, DNA微阵列, 原位杂交)
  • 产品和服务 (检测试剂盒, 仪器, 服务和软件)
  • What is the historic period, base year, and forecast period taken for North America Molecular Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Molecular Diagnostics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in North America Molecular Diagnostics Market?

    The North America Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Agilent Technologies Inc
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Novartis AG
  • Qiagen NV
  • Siemens Healthineers AG
  • TBG Diagnostics Limited
  • Thermo Fisher Scientific Inc
  • Who should buy this report?

    The North America Molecular Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.